Objective: to study the short and long term effectiveness of in situ replacement of infected aortic grafts with the lower extremity deep veins. Methods: forty-nine patients operated on for infrarenal aortic graft infection since 1990 were studied. Diagnosis of infection was based on clinical signs, bacteriological tests and typical findings on CT scan and leukocyte scan. The surgical treatment consisted in harvesting the femoral vein, total graft excision, thorough debridement and in situ reconstruction with the femoral veins. After discharge, the patients were followed at 6 monthly intervals with clinical examination, duplex and/or CT scan. Results: there were four in-hospital deaths (8%). One patient required above-knee amputation (2%) and there were two graft limb occlusions (4%). With a mean follow-up 41 months, another 13 patients died, unrelated to the operation (29%). There were no late amputations and only two late graft limb stenoses (4%). We have a 5 year survival rate of 60%, a 5 year limb salvage rate of 98%, and a 5 year primary patency rate of 91%. There were no cases of aneurysmal dilatation of vein grafts and no incidence of reinfection. Conclusion: in situ reconstruction with the lower extremity deep veins is in the long term a safe and attractive alternative in the treatment of infrarenal aortic graft infection.
Introduction
Deep infection remains the most feared complication after prosthetic infrarenal aortic surgery. It is an infrequent complication, affecting only 2% of the patients but if untreated it is invariably fatal. Local therapy with antibiotics is rarely sufficient and only indicated in high-risk patients with localised infection.
1±4 Extra anatomic bypass with total graft excision is considered to be the gold standard. However, there is a substantial problem with recurrent infection and complications related to the extra-anatomic technique. 1, 5 In order to avoid these complications, we started in situ reconstruction with the lower extremity deep veins. Following our previous preliminary publication, 6 the present report describes our further experience with extended follow-up.
Patients and Methods

Patients
Since 1990, 70 patients with infrarenal aortic graft infection were treated by an autogenous in situ reconstruction, using the lower extremity deep veins. Twenty-one patients presented with graft-enteric complications. These will be the subject of a subsequent report. In this study, we focus on 49 patients who presented with a primary graft infection in the absence of aorto-enteric complications. Data concerning demographics, preoperative presentation, operative details and postoperative period were retrieved from the prospective records, kept in the database of all operated patients in the Department of Vascular Surgery since 1990.
Operative procedure
The operation technique has already been described in previous reports. 6±8 With a ten-year experience we now emphasise certain details. Preoperative duplex ultrasound examination is essential to assess the patency and size of the femoral vein (FV). The operation starts with harvesting the FV from both legs. We take care to preserve the greater saphenous vein (GSV) since there are indications that this might lower the postoperative venous morbidity. However, in our series there were several patients where the GSV had already been removed in previous vascular interventions. There must be no FV-stump left at the junction of the common femoral vein to maintain a correct flow from the profunda femoris into the common femoral vein. To prevent contamination, the wounds are closed before laparotomy. The infected prosthesis is completely excised and most important of all, a thorough retroperitoneal debridement is performed. Samples of the infected tissues and graft are taken for bacteriology. Initially, we created an end-to-end anastomosis with the reversed veins sewn together in a pantaloon configuration (high bifurcation, Fig. 1A ).
Since 1995 we changed our technique and we actually prefer to downsize the infrarenal aortic cuff and to create an end-to-end anastomosis with only one vein while the second vein is connected more distally on the first one (low bifurcation, Fig. 1B ). The vein grafts are covered with viable tissues without leaving residual cavities. Omentoplasty is generally used at the proximal anastomosis and a rectus femoris muscle flap in the groin is provided if necessary (extensive groin infection). Wounds are closed on suction drains in the femoral region and in the retroperitoneum.
Postoperative management
Intermittent pneumatic compression for 5 days, low molecular weight heparin during the hospital stay and elastic stockings for 3 months were used to prevent venous thrombosis and hypertension. Intravenous antibiotic therapy was based on preoperative cultures and antibiotic sensitivity. In the absence of positive preoperative cultures, Vancomycin was started peroperatively after taking bacteriological samples. Antibiotic therapy was directed postoperatively if necessary and continued for 6 weeks. After discharge, all patients have been seen at 6-months intervals with clinical vascular examination and duplex ultrasound to evaluate the reconstruction. CT scan, leukocyte scan or angiography was only performed in selected cases.
Results
Patients
The mean age of the 49 patients was 65 years (47±78 years). There were 45 men and four women. Their primary operation was performed for occlusive disease in 34 cases and for aneurysms in 15 cases. Eleven of these primary operations were performed in our Department. All procedures were done with Dacron grafts and included aorto-bi-femoral reconstructions (n 43), aorto-bi-iliac grafts (n 3) and aorto-aortic tube grafts (n 3). The mean interval between the initial operation and the diagnosis of prosthetic infection was 59 months (1±307 months). Twenty-three patients received already some treatment in an attempt to control the infection: abscess drainage (n 13), correction of false aneurysm (n 3), other vascular procedures (n 3) or antibiotics (n 4). Suspicion of infection was based on clinical signs ( Table 1 ). Out of the four patients suffering severe ischemic complications, two presented with rest pain and another two with acute ischemia. Evidence of infection was achieved by CT scan, by leukocyte scan and by bacteriological tests. CT scan showed perigraft masses, fluid or abscesses, located in the retroperitoneum in 23 cases and in the groin in 34 cases. Indirect signs as vertebral column invasion (n 2) or hydronephrosis (n 2) helped with the diagnosis. Leukocyte scan was performed in 22 patients and 18 were positive. The infections were due to a variety of organisms with staphylococci being the most frequent one ( Table 2 ). Other organisms included Escherichia coli, Pseudomonas aeruginosa and MRSA. Polymicrobial infections were seen in 10 patients while no organisms were cultured in four patients.
Operation
All but two reconstructions were done on an elective base. The femoral veins were always harvested from both limbs. The infected prosthesis was completely excised in all patients. The following reconstructions were performed: 44 aorto-bi-femoral bypasses, three aorto-bi-iliac and two aorto-iliac/femoral bypasses. For technical reasons, the three aortic tube grafts were replaced by an venous aorto-bi-iliac graft. The high bifurcation technique was used in 20 patients and the low bifurcation technique in 29 patients. One patient required splenectomy for a per-operative trauma. Reimplantation of a renal artery was necessary in one case and reimplantation of an internal iliac artery in two cases. Hydro-ureteronephrosis was treated by a double-J stent in two patients. Omentoplasty was performed in 25 patients. Concomitant vascular procedures were one femorofibular venous homograft and one saphenous vein femoropopliteal bypass below the knee. A muscle flap in the groin was used in 6 cases. A fasciotomy was never done and one surgical team performed all procedures.
Early results
There were 4 in-hospital deaths (8%) ( Table 3) . Two patients died due to abdominal complications and multiple organ system failure: one sigmoid necrosis and one intra-abdominal bleeding. The third patient developed a fatal myocardial infarction and the fourth died after a cerebrovascular accident. Postoperative morbidity included revision for major bleeding in four cases. Respiratory complications were encountered in 10 patients: one with Adult Respiratory Distress Syndrome, eight with pneumonia and one lung embolism. Above-knee amputation was necessary in only one patient (2%) after occlusion of the femorofibular venous homograft, performed concomitantly to the venous reconstruction. There were two graft limb occlusions (4%). One was treated by thrombectomy and subsequent stenting while the second graft thrombosis was left alone (asymptomatic occlusion).
Late results
The mean follow-up time was 41 months (range 1±101 months). There were 13 late deaths (29%), unrelated to the operative reconstruction (six myocardial infarctions, three lung cancers, and four other cancers). The 5 year survival rate was 60% ( Fig. 2A ). There were no late amputations (5 years limb salvage rate of 98%, Fig. 2B ) but two late graft limb stenoses (4%), both treated by balloon dilation and stenting (5 year primary patency rate of 91%, Fig. 2C ). Venous morbidity was low and only three patients (6%) required elastic stockings longer than 6 months. Careful follow-up with duplex ultrasound and/or CT scan showed continuous function of the venous graft without any aneurysmal degeneration (Fig. 3 ). Finally and most importantly, infection remained cured in all patients.
Discussion
Graft excision and extra-anatomic bypass is the traditional treatment of infrarenal aortofemoral prosthetic infection. 1, 2 Results may have been improved over the years but mortality and morbidity remains high. 1, 5 Dissatisfaction with this technique led to a revival of in situ reconstruction over the last decade. In situ reconstruction was introduced mainly to avoid aortic stump blow-out, extra-anatomic graft failure, reinfection and the physiologic stress associated with multiple or staged procedures. 9 Nevertheless, our results show that the mortality rates also compete favourably with those of recent reports on graft excision and extra-anatomic bypass. Seeger et al. reported in 2000 on 36 patients treated with the traditional technique. 5 Operative mortality was 19%, 11% needed amputation and 35% had graft failure. There was one reinfection and one aortic stump disruption.
Apart from the femoral vein, several authors have described different methods of in situ reconstruction. The use of the greater saphenous vein has been abandoned due to poor patency in the long term. Some studies report failure rates of 60%. Intimal hyperplasia also seems to be important in these small veingrafts. 10, 11 In our department, arterial homografts are sometimes used for lack of deep veins. 12 With the new techniques of cryopreservation, they have certainly the advantage of availability and versatility. 13, 14 Nevertheless, they are less resistant to infection than autogenous tissues and late degeneration remains a possible risk. Kieffer et al. reported in 1997 his experience in 100 patients with aortofemoral prosthetic infection treated by arterial homografts. 13 The operative mortality rate was 19% for the patients with only isolated prosthetic infection. There were two reinfections, two late aortic ruptures and five patients showed aneurysmal dilatation of the homograft. During follow-up, 20 occlusive lesions were observed (25%). His conclusion was that this technique seemed to be a good alternative but that complete protection against persistent or recurrent infection cannot be guaranteed and that late deterioration is a possible risk. This was also our experience when we reported a 6.6% reinfection rate and a 23% incidence of occlusive complications in a series of 30 patients. 12 In addition, Verhelst et al. documented in a multicentric study a high failure rate in case of virulent infections. 15 The experience of in situ reconstruction with impregnated Dacron grafts is still limited. Hayes 
Ten-year Experience in Autogenous Reconstruction
et al. reported in 1999 on 11 patients over a period of 7 years, treated by in situ replacement with a rifampicin-bonded prosthesis. 16 The operative mortality rate was 18.2% and seven patients remained alive and free of infection. The conclusion was that the results appeared to be favourable but the MRSA infection was associated with a poor prognosis. In a recent review on the role of rifampicin-impregnated grafts, Earnshaw concluded that this technique is probably best avoided in patients with extensive perigraft infection. 17 Young et al. reported also in 1999 on 25 patients treated with a Dacrongraft and nine of them where rifampicin-soaked. 18 They present an 8% operative mortality, a 100% limb salvage rate and an 86% 5 year graft patency rate. On the other hand, they have a 22% reinfection rate, despite lifelong antibiotics. Nevertheless, there was a trend of lower reinfection rates with rifampicin-impregnated grafts. More recently, Zegelman and Gu È nther reported their experience with silver coated grafts on a series of 62 patients. 19 The operative mortality rate of 6.5% is very acceptable but there is still a reinfection rate of 6.5%.
The major advantage of the femoral vein is its high resistance to infection. With this autologous graft, we had indeed no reinfections in our series. This confirms the reports of Clagett et al. who also stressed the durability and resistance of the femoral vein in high virulent infections. 7 However, reinfection has been reported with P. aeruginosa 20 and MRSA. 21 It has also been reported that P. aeruginosa or an aggressive mix of bacteria could cause an acute disruption or dehiscence of the suture line, even in grafts constructed from autologous material. 22 In our series there were two patients with P. aeruginosa and two with MRSA infection. All four patients recovered without problems. Although caution might be advised in these cases, we feel that our results might be at least partially explained by our operative technique with extensive debridement of all infected tissues and the prolonged antibiotic regimen we use postoperatively. Furthermore, there is only minimal venous morbidity after harvesting the femoral vein 23±25 and until now, the reports about this type of in situ reconstruction never showed aneurysmal dilatation of the vein graft. 7,20,26±28 On the other hand, it is agreed that in situ reconstruction with the femoral vein is a technically more demanding and time-consuming procedure, lasting around 6 h. Harvesting is also more difficult after previous femoropopliteal bypass. In addition, there might be a problem with the availability and the amount of venous material. Both femoral veins are certainly sufficient for the aorto-bi-femoral reconstruction but concomitant vascular procedures may create a problem. The only contra-indication for harvesting the femoral vein is previous deep venous thrombosis. Despite these limitations, we were able to use the femoral vein in more than 80% of the patients presenting with an infrarenal aortic graft infection.
Treatment of aortic graft infection has to focus on patient's survival, eradication of infection and revascularisation of the lower extremities by a method, which is safe, durable and does not become infected itself. Based on this assumption, our results are certainly gratifying. We have an operative survival of 92% with only one major amputation. The 5 year survival rate is 60% but none of the late deaths were related to the reconstructive procedure. In addition there were no reinfections and the venous reconstruction proved to be functional and durable on the long term.
